Additional Proxy Soliciting Materials (definitive) (defa14a)
26 Mayo 2023 - 3:23PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934
| | | | | | | | | | | | | | |
| Filed by the Registrant ☒ | | | |
| Filed by a Party other than the Registrant ☐ | | | |
| Check the appropriate box: | | | |
| ☐ | Preliminary Proxy Statement | | | |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ | Definitive Proxy Statement | | | |
| ☒ | Definitive Additional Materials | | | |
| ☐ | Soliciting Material Pursuant to §240.14a-12 | |
| | | | | | | | | | | | | | |
| GRI BIO, INC. |
| (Name of Registrant as Specified in Its Charter) |
| (Name of Person(s) Filing Proxy Statement, if other than the Registrant) |
| | | | | | | | | | | | | | |
| Payment of Filing Fee (Check the appropriate box): |
| ☒ | No fee required |
| ☐ | Fee paid previously with preliminary materials |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |
Vallon Pharmaceuticals (NASDAQ:VLON)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Vallon Pharmaceuticals (NASDAQ:VLON)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
